Preclinical animal studies were conducted almost exclusively in SOD1-G93A transgenic rodents; however, SOD1 mutations are only 2% of ALS cases (< 10% ALS cases are familial; ~ 20% of these have SOD1 mutations). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.